Cure My Disease
Don't miss your cure!
Please sign in to follow a disease.
Clinical trials sponsored by Menarini Group, explained in plain language.
This study is testing the safety and how the body handles Vaborem, a combination of two antibiotics (meropenem and vaborbactam), in children from birth to under 18 years old who have serious Gram-negative bacterial infections. All 44 participants will receive the drug intravenous…
Phase 2 • Sponsor: Menarini Group • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC